Myriad Genetics Inc (MYGN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Myriad Genetics Inc (MYGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7428
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

Myriad Genetics Inc (MYGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Myriad Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Myriad Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Myriad Genetics Inc, Medical Equipment, Deal Details 13
Venture Financing 13
Myriad Genetics to Raise Funds through Venture Financing 13
AssureRx Health Raises Additional USD15 Million in Series D Financing 14
AssureRx Health Raises USD7 Million in Venture Financing 15
Counsyl Raises US$28 Million In Series D Financing 17
RainDance Technologies Raises US$20 Million In Series E Financing 18
Crescendo Bioscience Raises US$28 Million In Series D Financing 20
Counsyl Secures USD7.5 Million in Series C Funding 22
Assurex Health Secures USD12.5 Million in Series C Funding Round 23
Counsyl Secures USD34 Million in Series B Round of Funding 24
Assurex Health Secures USD8 Million in Venture Funding Round 25
Private Equity 26
Perceptive Advisors Invests USD80 Million in Counsyl 26
Partnerships 27
Myriad Genetics Enters into Licensing Agreement with Institut Curie and INSERM 27
Myriad Genetics Enters into Licensing Agreement With Children’s Medical Center 28
Myriad Genetics Enters into Licensing Agreement with University of Texas 29
Myriad Genetics Enters Into Licensing Agreement For RAD51C Gene 30
Myriad Genetics and Pfizer Enter into Agreement 31
Sividon Diagnostics Enters into Co-Marketing Agreement with Virchow Labs and Ready Ruixin 32
Myriad Genetics Expands Agreement with AstraZeneca 33
Myriad Genetics Enters Into Co-Marketing Agreement With Sividon Diagnostics For EndoPredict Test 34
Myriad Enters Into Research Agreement With Janssen Research & Development 35
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 36
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 37
Mount Sinai Genetic Testing Lab And Counsyl Partner To Expand Screening For Genetic Diseases 38
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 39
Acquisition 40
Myriad Genetics Acquires Counsyl for USD375 Million 40
Myriad Genetics Acquires Assurex Health for USD351.6 Million 42
Myriad Genetics Acquires Sividon Diagnostics 44
Myriad Genetics Completes Acquisition Of Crescendo Bioscience For US$270 Million 45
Myriad Genetics Inc – Key Competitors 47
Myriad Genetics Inc – Key Employees 48
Myriad Genetics Inc – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 51
Financial Announcements 51
Aug 21, 2018: Myriad Genetics reports fiscal fourth-quarter and full-year 2018 financial results 51
May 08, 2018: Myriad Genetics Reports Fiscal Third-Quarter 2018 Financial Results 54
Feb 06, 2018: Myriad Genetics Reports Fiscal Second-Quarter 2018 Financial Results 56
Nov 07, 2017: Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results 58
May 02, 2017: Myriad Genetics Reports Fiscal Third-Quarter 2017 Financial Results 59
Feb 07, 2017: Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results 61
Legal and Regulatory 63
Apr 23, 2018: Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against  Myriad Genetics, Inc. 63
Government and Public Interest 64
Sep 25, 2018: Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association 64
Product News 65
Apr 17, 2017: Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database 65
Other Significant Developments 67
Oct 02, 2017: Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month 67
Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Tables
Myriad Genetics Inc, Medical Equipment, Key Facts, 2018 2
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Myriad Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Myriad Genetics Inc, Deals By Market, 2012 to YTD 2018 9
Myriad Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Myriad Genetics to Raise Funds through Venture Financing 13
AssureRx Health Raises Additional USD15 Million in Series D Financing 14
AssureRx Health Raises USD7 Million in Venture Financing 15
Counsyl Raises US$28 Million In Series D Financing 17
RainDance Technologies Raises US$20 Million In Series E Financing 18
Crescendo Bioscience Raises US$28 Million In Series D Financing 20
Counsyl Secures USD7.5 Million in Series C Funding 22
Assurex Health Secures USD12.5 Million in Series C Funding Round 23
Counsyl Secures USD34 Million in Series B Round of Funding 24
Assurex Health Secures USD8 Million in Venture Funding Round 25
Perceptive Advisors Invests USD80 Million in Counsyl 26
Myriad Genetics Enters into Licensing Agreement with Institut Curie and INSERM 27
Myriad Genetics Enters into Licensing Agreement With Children’s Medical Center 28
Myriad Genetics Enters into Licensing Agreement with University of Texas 29
Myriad Genetics Enters Into Licensing Agreement For RAD51C Gene 30
Myriad Genetics and Pfizer Enter into Agreement 31
Sividon Diagnostics Enters into Co-Marketing Agreement with Virchow Labs and Ready Ruixin 32
Myriad Genetics Expands Agreement with AstraZeneca 33
Myriad Genetics Enters Into Co-Marketing Agreement With Sividon Diagnostics For EndoPredict Test 34
Myriad Enters Into Research Agreement With Janssen Research & Development 35
Myriad Genetics Expands Agreement with AstraZeneca for Olaparib 36
DaVita Enters Into Agreement With Myriad Genetics For Protein Biomarker Discovery 37
Mount Sinai Genetic Testing Lab And Counsyl Partner To Expand Screening For Genetic Diseases 38
Bio-Rad Labs Enters Into Distribution Agreement With Myriad RBM For Multiplex Biomarker Kits 39
Myriad Genetics Acquires Counsyl for USD375 Million 40
Myriad Genetics Acquires Assurex Health for USD351.6 Million 42
Myriad Genetics Acquires Sividon Diagnostics 44
Myriad Genetics Completes Acquisition Of Crescendo Bioscience For US$270 Million 45
Myriad Genetics Inc, Key Competitors 47
Myriad Genetics Inc, Key Employees 48
Myriad Genetics Inc, Subsidiaries 49

List of Figures
Myriad Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Myriad Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Myriad Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Myriad Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Myriad Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Myriad Genetics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Myriad Genetics Inc (MYGN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Scotiabank Peru S.A.A.:企業の戦略・SWOT・財務分析
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Life Time Fitness, Inc:企業の戦略・SWOT・財務分析
    Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report Summary Life Time Fitness, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corporation Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Thermo Fisher Scientific Inc.:企業の戦略・SWOT・財務情報
    Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report Summary Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Palfinger AG (PAL):企業の財務・戦略的SWOT分析
    Palfinger AG (PAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Summer Infant, Inc.:企業の戦略・SWOT・財務情報
    Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report Summary Summer Infant, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Kazia Therapeutics Ltd (KZA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kazia Therapeutics Limited (Kazia Therapeutics), is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (A …
  • Grindeks (GRD1R):製薬・医療:M&Aディール及び事業提携情報
    Summary Grindeks focuses on the research, development, manufacture and marketing of novel pharmaceuticals, generic products and active pharmaceutical ingredients (APIs). Its products are indicated for treating diseases in cardiovascular, central nervous system (CNS) and cancer therapeutic categories …
  • Daicel Corporation (4202):企業の財務・戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PerkinElmer Inc (PKI):企業の製品パイプライン分析
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …
  • EPAM Systems Inc (EPAM):企業の財務・戦略的SWOT分析
    EPAM Systems Inc (EPAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務情報
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • Federal Electricity & Water Authority:企業の戦略的SWOT分析
    Federal Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Southern Co (SO):電力:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Compumedics Ltd (CMP):企業の財務・戦略的SWOT分析
    Summary Compumedics Ltd (Compumedics) is a medical device company. It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems. It provides product categories such as sleep diagnostics, neurology diagnosti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆